LightPath Technologies, Inc. — Form 10-Q Summary
Reporting period: Fiscal second quarter and six months ended December 31, 2012 (fiscal 2013). The company manufactures precision optical components and assemblies for industrial, medical, defense, communications and other markets. Financial statements are unaudited.
Financial performance and position
| Metric | Three months ended Dec. 31, 2012 | Six months ended Dec. 31, 2012 | Comparable 2011 period |
|---|---|---|---|
| Revenue | $2.917 million | $5.808 million | $2.672 million; $5.405 million |
| Gross margin | $1.266 million; 43% of revenue | $2.444 million; 42% of revenue | $0.844 million; 32%; $1.926 million; 36% |
| Operating income (loss) | $(25,120) | $(51,639) | $(319,861); $(528,794) |
| Net income (loss), as reported in statements of operations | $140,772 | $241,993 | $(343,299); $(541,746) |
| Operating cash flow | Not separately presented | $(90,321) | $256,607 |
- Revenue increased 9% for the quarter and 7% for the six-month period. Gross margin improved, aided by higher sales, lower manufacturing costs, improved labor productivity and lower-cost glass transitions.
- Cash and equivalents were $1.778 million at December 31, down from $2.354 million at June 30, 2012. Six-month capital expenditures were $489,000; cash decreased by $577,000.
- Current assets were $6.485 million and current liabilities $2.980 million. Total liabilities were $4.104 million; stockholders’ equity was $4.477 million. The company reported an accumulated deficit of $204.4 million.
- Outstanding 8% convertible debentures totaled $1.088 million, including $1.013 million owed to related parties. They are due August 1, 2013; the filing reports them as current liabilities at December 31.
- Six-month EBITDA, a non-GAAP measure, was $697,000 versus $77,000 in the prior-year period. Management attributes improvement partly to higher gross margin, lower development spending, license income and a warrant fair-value gain.
Material changes and unusual items
- Quarterly net income improved from a loss in the prior year. However, a $170,000 second-quarter gain from remeasuring June 2012 warrants contributed materially; the six-month gain was $265,336. The liability is Level 3 and subject to recurring fair-value estimates.
- The company recognized $50,000 of license income in the first quarter under an exclusive five-year GRADIUM intellectual-property license. The agreement provides for $150,000 in fees and royalties beginning in year four; no license income was recognized in the second quarter.
- A $1.1 million Raytheon purchase order supports development of infrared-optics manufacturing processes. Through December 31, the company had recognized approximately $1.02 million of revenue but invoiced $743,500; approximately $279,500 was recorded as other receivables, with another $100,000 in accounts receivable. Completion was expected by July 2013.
- The June 2012 equity placement generated gross proceeds of approximately $1.983 million and included warrants. Warrant-price adjustment provisions require liability classification and fair-value remeasurement. Share issuance increased weighted-average shares materially year over year.
Outlook, risks and contingencies
- Management expected operating cash flow to improve in the fourth quarter of fiscal 2013, citing bookings, quote activity, the 12-month backlog and cost-reduction efforts. It anticipated infrared-product growth beginning more meaningfully in the fourth quarter and continuing into fiscal 2014.
- The 12-month backlog was $4.64 million at December 31, 2012, approximately $813,000 higher than at December 31, 2011; it was $4.89 million at June 30, 2012. Management described markets as weak and choppy and noted a lower second-quarter booking rate.
- Cash management remains a primary concern. The company has a history of operating losses, no borrowing availability or committed financing, and may need external capital if cash generation is insufficient. Management warned that financing may not be available on acceptable terms.
- Risks include customer concentration, weaker sales or collections, higher material and labor costs, failure to achieve planned production efficiencies, and discretionary spending. Management also noted that strategic alternatives could be considered if financing or operating improvements prove inadequate.
- Disclosure controls were assessed as effective; no material change in internal control over financial reporting was reported. The filing reports no legal proceedings.
Important facts for investors to verify
- Conflicting earnings figures: The statements of operations report net income of $140,772 for the quarter and $241,993 for six months, while the EPS note gives $149,898 and $251,119, respectively. The filing text does not reconcile these differences; verify against the filed financial statements and any corrections.
- Cash runway and financing: Assess cash use, supplier payment arrangements, expected operating cash flow and ability to refinance or repay the debentures due August 2013.
- Warrant valuation: Evaluate the effect and volatility of the Level 3 warrant-liability remeasurement on reported earnings and the potential dilution from warrants and convertible debt.
- Raytheon project: Monitor project completion, cost estimates, collection of unbilled receivables and whether revenue recognized using the cost-to-cost method remains supportable.
- Backlog and growth assumptions: Confirm conversion of backlog and quoted opportunities into shipments, particularly for infrared and precision molded optics, amid the reported weak and uneven markets.